The accurate diagnosis of adult pheochromocytoma and paraganglioma necessitates a multidisciplinary approach that includes clinical history, biochemical testing, and multimodality imaging such as computed tomography, magnetic resonance imaging, and nuclear medicine studies. This review illustrates the different imaging characteristics of primary adult pheochromocytomas as well as both sympathetic and parasympathetic paragangliomas. The review also describes known genetic associations and shows common metastatic patterns. Knowledge of the diverse appearance of pheochromocytomas and paragangliomas can result in early initial diagnosis or detection of disease recurrence thereby affecting patient management and prognosis.
Introduction
Neural crest cells constitute a multipotent population from which numerous cellular lineages including melanocytes, craniofacial cartilage and bone, smooth muscle, neurons, and glia as well as tumors such as pheochromocytomas, paragangliomas, and neuroblastomas arise. Pheochromocytoma cells differentiate from epinephrine secreting, neural crest-derived, precursor cells of the adrenal medulla [1] . Paraganglia cells also originate from the neural crest, but differentiate into sympathetic and parasympathetic subtypes that can give rise to paragangliomas. Sympathetic paragangliomas secrete norepinephrine; parasympathetic paragangliomas are nonsecretory and typically occur in the head and neck [2] . Pheochromocytomas and paragangliomas are rare tumors with a combined annual incidence of less than 1 in 300,000 [2] . Traditionally, pheochromocytomas are described by the rule of 10s where 10% are metastatic, 10% are bilateral, 10% are familial, 10% are extraadrenal (paragangliomas), and 10% are not associated with hypertension [2] . Although the rule of 10s is a helpful approximation, current research has stressed the increased importance of genetic predisposition in the development of pheochromocytomas and paragangliomas. Furthermore, the rate of metastases varies widely depending on the tumor origin [3] . Only 210% of pheochromocytomas metastasize compared with 2070% of extraadrenal paragangliomas [3] . The diagnosis of pheochromocytoma and paraganglioma depends on the clinical history, the presence of urinary or circulating catecholamines/metabolites, imaging findings, and tissue histopathology. Patients can be asymptomatic or symptomatic, presenting with episodic hypertension, tachycardia, palpitations, perspiration, pallor, headache, and nonspecific abdominal or flank pain [2] . Although pheochromocytomas and paragangliomas can have similar clinical and radiologic features, these tumors differ in prognosis and likelihood of metastatic spread [4, 5] . This pictorial review demonstrates the common imaging characteristics of pheochromocytomas and paragangliomas using multiple imaging modalities and describes some common genetic syndrome associations. Since the anatomic location of the tumor changes the prognosis, numerous sites of both adrenal and extraadrenal tumors are illustrated. This review also explores common metastatic patterns.
Pheochromocytoma and paraganglioma imaging findings
On computed tomography (CT), the typical appearance of a pheochromocytoma or paraganglioma is a mass with an unenhanced density greater than 10 Hounsfield units (HU), avid contrast enhancement due to a rich capillary network, and delayed washout [1] (Fig. 1) . Internal hemorrhage can sometimes be seen within the tumor (Fig. 2) . Cystic changes, necrosis, and internal calcifications are commonly described [6] . Rarely, these masses show low attenuation or minimal enhancement [1] . By comparison, lipid-rich adrenal adenomas tend to have low density on unenhanced CT (510 HU) and show early washout [7] . The theoretical risk of precipitating a hypertensive crisis has previously prevented intravenous iodinated contrast administration in individuals with suspected or known pheochromocytomas, however no adverse events were reported in a retrospective study of 25 patients with paragangliomas and pheochromocytomas who received nonionic iodinated contrast [8] . Contrast has also been used in our practice without any reactions (Fig. 2) .
The improved tissue contrast of magnetic resonance imaging (MRI) allows further characterization of adrenal lesions [9] . In general, pheochromocytomas demonstrate T2 prolongation and variable, although often intense, contrast enhancement resulting in the light bulb sign (Fig. 3 ) [9] . Up to 35% of pheochromocytomas, however, fail to demonstrate this typical T2 prolongation [9] . Internal hemorrhage and cystic components contribute to the heterogeneous MRI appearance of these tumors. Additional use of opposed phase imaging can be helpful as pheochromocytomas and paragangliomas do not exhibit dropout of signal on opposed phase imaging, but many lipid-rich adenomas do [10] . Ideally, the biochemical diagnosis is made before imaging is performed. However, functional imaging is a guanethidine analog that is taken up and stored in vesicles within cells of the sympathomedullary system [11] . Although MIBG can be labeled with either ]MIBG because the use of SPECT improves sensitivity and anatomic localization, whereas the low count rate and high energy collimators needed for 131 I makes SPECT more difficult to perform and yields worse image quality [11] . Prior to an [
123 I]MIBG study, the patient must be screened for medications that could interfere with MIBG uptake, necessitating discussion with the referring clinician. The patient should also receive supersaturated potassium iodide (SSKI) or Lugol solution to block radiotracer uptake in the thyroid [11] . Somatostatin analogs such as octreotide bind to cellular hormonal receptors important for inhibition of neuroendocrine hormone synthesis [11] . The extent of uptake of [
111
In]octreotide is variable and dependent on the profile/subtypes of somatostatin receptors in the tumor. In patients with an incidental mass that is suspected to be a pheochromocytoma or paraganglioma, the choice of initial imaging radiotracer can be difficult. In general, [
123 I]MIBG is thought to be slightly more sensitive than [
111 In]octreotide for the site of primary disease and is often the radiotracer of choice [12] .
[
111 In]octreotide has high sensitivity for metastatic disease and can be positive in tumors that have no MIBG uptake [1, 11] . [11] . To date, PET remains in the realm of investigation playing a predominantly complementary role in the evaluation of this patient population.
There is no consensus on the order in which radiologic tests should be performed for patients with suspected neural crest tumors. A biochemical diagnosis is key, although anatomic imaging with CT or MRI and functional imaging with [ 
Hereditary syndromes
Pheochromocytomas and paragangliomas can occur either sporadically or due to germline mutations with at least 9 suspect genes identified [13] . Numerous named genetic syndromes have been associated with pheochromocytoma and paraganglioma. Von Hippel-Lindau (VHL) is an autosomal dominant disease caused by VHL gene mutations that predisposes individuals to central nervous system hemangioblastomas, renal cysts, renal cell carcinoma, pancreatic cysts, retinal angiomas, and pheochromocytomas (Fig. 1) . Carney Stratakis syndrome is a rare association of familial paraganglioma and gastrointestinal tumor (Fig. 4) . Other associations include multiple endocrine neoplasia (MEN2), neurofibromatosis type I (NF1), Sturge-Weber syndrome, and Carney syndrome [2] . Genetic analysis has also linked mutations in the succinate dehydrogenase (SDH) genes to the development of parangangliomas and pheochromocytomas [2] . At least 4 paraganglioma syndromes named paraganglioma syndrome IIV have been linked to mutations in the SDHD, SDH5, SDHC, and SDHB, respectively [2] . Recent research suggests that the current list of associated genetic mutations is not yet complete [2] .
Extraadrenal sympathetic paraganglioma
Extraadrenal paragangliomas behave more aggressively than their adrenal counterparts with metastases occurring in 2070% of cases [3, 4] . Retroperitoneal paragangliomas are classically associated with the organ of Zuckerandl, the chromaffin paraaortic tissue between the origin of the inferior mesenteric artery and the aortic bifurcation (Fig. 5) . Together with the organ of Zuckerandl, the infradiaphragmatic paraaortic region and mediastinum constitute the three most common locations of extraadrenal paragangliomas [4] (Fig. 6) . The urinary bladder is another common site of paraganglioma. Catecholaminesecreting tumors in this location can produce any of the typical sympathetic symptoms such as paroxysmal hypertension, tachycardia, headache, perspiration, palpitations, pallor, weight loss, and hyperglycemia in addition to painless hematuria and micturition syncope [14] (Fig. 4) .
Extraadrenal parasympathetic paraganglioma
Parasympathetic, nonsecretory paragangliomas in the head and neck are also commonly reported. Tumors in the carotid body, for example, are well known clinical entities associated with a lower rate of metastases than their retroperitoneal counterparts and characteristically described as well-defined soft tissue masses within the carotid space splaying the carotid bifurcation [3, 15] ( Fig. 7) . Other locations for paragangliomas include the glomus jugulare, glomus vagale, and glomus tympanicum. Glomus jugulare tumors arise from the jugular foramen of the skull base in association with branches from either the vagus or glossopharyngeal nerve. These tumors are locally aggressive with extension into the adjacent bones and intracranial structures but are hormonally silent [15] ( Fig. 8) .
Metastatic patterns
No reliable histologic features can currently distinguish between benign and malignant tumors. In addition to local recurrence at the site of surgical resection, hematogenous and lymphatic metastases are common [3] . 111 In]Octreotide scan demonstrates radiotracer uptake in the right lower lobe (white arrow) compatible with metastases. Uptake was also noted in the mediastinum and bilateral hila consistent with lymphadenopathy (black arrows).
Metastatic disease is often diagnosed when tumor foci are identified at sites where chromaffin tissue is absent. Common sites of metastatic spread include regional lymph nodes, bone, liver, and lung (Fig. 9) . One can evaluate for metastatic disease using multiple imaging modalities including CT, MR, MIBG and PET/ CT (Figs. 10 and 11 ). In addition, osseous metastases from pheochromocytomas and paragangliomas may demonstrate radiotracer uptake on bone scans (Fig. 12) .
Conclusion
Clinical suspicion for a pheochromocytoma and paraganglioma often begins with the patient history and is confirmed with biochemical testing. The discovery of a primary enhancing mass in a midline or paramidline location should prompt consideration of neural crest lesions. Locating and staging these tumors requires a combination of anatomic and functional imaging modalities. Although contrast-enhanced MRI was preferred in the past for anatomic imaging due to fear of inducing an adrenal crisis with iodinated contrast, contrast-enhanced CT (using nonionic iodinated contrast) is now considered the best initial anatomic study with MRI reserved Figure 10 A 52-year-old woman initially presented with a sensation of mid-epigastric fullness. After initial imaging (not available), the patient underwent surgical excision of a 9-cm abdominal mass with the diagnosis of paraganglioma. for problem solving. Functional imaging is often performed concurrently with [ 123 I]MIBG serving as the preferred agent due to its sensitivity and specificity profile [16] . Although these tumors have traditionally been associated with the 10% rule, improved imaging detection and outcome data show that the true story is more complex and prognosis varies depending on the tumor type and location.
